Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, originally developed for type 2 diabetes management, has emerged as a powerful tool for weight loss in patients who meet specific medical criteria. The medication works by activating GLP-1 receptors in the brain and digestive system, leading to sustained appetite suppression and improved metabolic function. Understanding who qualifies for semaglutide therapy is the first step toward exploring whether this treatment aligns with your health goals.
Medical Eligibility Requirements for Semaglutide Therapy
Semaglutide is approved for weight loss in adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who also have at least one weight-related health condition such as high blood pressure, type 2 diabetes, or heart disease. Your healthcare provider will evaluate your complete medical history, current medications, and metabolic profile to determine if semaglutide is appropriate for your situation. Certain conditions—including a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or pregnancy—make semaglutide unsuitable.
PlexusDx works with patients to assess eligibility through a comprehensive medical intake process. The initial consultation includes discussion of your weight loss history, previous treatments you've tried, and any underlying health conditions that might affect your response to therapy. This personalized approach ensures that only patients who can safely benefit from semaglutide are enrolled in treatment.
How Age and Medical History Impact Semaglutide Candidacy
Semaglutide is approved for adults aged 18 and older, though the medication has been extensively studied in patients across a wide age range. Older adults can use semaglutide safely, though dosing adjustments may be needed if you have kidney or liver function changes. Patients with a history of thyroid problems, pancreatitis, gallbladder disease, or diabetic retinopathy require closer monitoring and discussion with their provider before starting treatment.
Your detailed medical history helps PlexusDx clinicians determine the safest starting dose and escalation schedule. Patients with multiple weight-related conditions often see the greatest benefit, as semaglutide addresses the underlying metabolic dysfunction driving both weight gain and chronic disease. Open communication about past weight loss attempts, medication responses, and family health history allows for truly individualized treatment planning.
Genetic Factors That Shape Your Semaglutide Response
Recent research has identified specific genetic variants that influence how effectively patients respond to GLP-1 medications like semaglutide. Variations in the GLP-1 receptor gene, FTO gene (associated with appetite regulation), MC4R gene, and GIPR gene can predict whether you'll experience robust weight loss or a more modest response to therapy. Understanding your genetic peptide pathways allows for smarter medication selection and more realistic outcome expectations.
PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 150+ genetic insights to map your individual response profile before or after starting treatment. This test identifies whether your genetic makeup predisposes you to strong GLP-1 receptor sensitivity, altered appetite signaling, or metabolic characteristics that might benefit from a different compound like tirzepatide. Patients who complete genetic testing gain personalized guidance on dose optimization and medication choice, available for $99 as an add-on after your first month of treatment.
Access to Semaglutide Through PlexusDx Without Insurance
One major barrier to semaglutide access is cost—brand-name versions can exceed $1,000 per month even with insurance. PlexusDx removes this barrier by offering compounded semaglutide injections from licensed 503A compounding pharmacies starting at $149 per month, with no insurance required and no membership fees. Compounded medications are formulated to the same specifications as brand-name drugs but at a fraction of the cost, making GLP-1 therapy accessible to far more patients.
PlexusDx serves patients across all 50 states with flexible commitment tiers and HSA/FSA eligibility for additional savings. Your dose may increase over time as your body adjusts, but PlexusDx maintains consistent pricing—you'll never pay more for a higher dose. The straightforward pricing structure eliminates surprise costs and makes it easy to budget for long-term weight loss support. Getting started requires only an online medical consultation and approval from a PlexusDx clinician; medications are shipped directly to your home.
Contraindications and Safety Considerations
Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2), due to animal studies showing thyroid C-cell tumors. Pregnant patients or those planning pregnancy should not use semaglutide, as the medication may harm fetal development. Patients with severe kidney disease, severe allergic reactions to semaglutide or other GLP-1 agonists, or uncontrolled diabetic retinopathy require alternative treatment approaches.
Common side effects include nausea, vomiting, diarrhea, and constipation—most mild and temporary as your body adjusts. More serious but rare events include pancreatitis (severe abdominal pain), gallbladder issues, and thyroid inflammation. PlexusDx provides detailed safety education and ongoing monitoring to help you recognize concerning symptoms early. If you develop severe abdominal pain, persistent vomiting, or signs of allergic reaction, contact your provider or seek emergency care immediately.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
I have a BMI of 28 but no weight-related health conditions. Can I still use semaglutide?
Standard approval requires either a BMI of 30+ or a BMI of 27+ with at least one weight-related condition like hypertension, type 2 diabetes, or cardiovascular disease. If you fall below these thresholds, PlexusDx clinicians can discuss whether you meet criteria under other circumstances or whether lifestyle modification or alternative treatments might be better first steps.
How does semaglutide actually cause weight loss?
Semaglutide activates GLP-1 receptors in your brain's appetite center and in your digestive system, which slows how fast your stomach empties food into the intestines and increases feelings of fullness after smaller meals. This dual action reduces overall calorie intake naturally, without requiring extreme dietary restriction. Clinical trials show patients lose an average of 15-20% of body weight over 68 weeks when combining semaglutide with modest lifestyle changes.
Is compounded semaglutide as safe and effective as the brand-name version?
Compounded semaglutide from licensed 503A pharmacies is formulated to identical pharmaceutical standards as brand-name medications. PlexusDx partners only with licensed compounding pharmacies that follow strict quality controls, sterility testing, and ingredient verification. The active ingredient is the same, and patient outcomes are equivalent—the difference is price, making compounded semaglutide a cost-effective alternative starting at $149/mo.
What happens if I have side effects like severe nausea?
Mild nausea typically improves within days to weeks as your body adjusts, but severe or persistent nausea should be reported to your PlexusDx clinician immediately. Your provider can slow your dose escalation, recommend anti-nausea strategies, or discuss whether semaglutide remains the right choice. Some patients respond better to alternative GLP-1 compounds like tirzepatide, which can be evaluated after your initial treatment period.
How does the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?
The PlexusDx Precision Peptide Genetic Test analyzes variants in the GLP1R, GIPR, FTO, and MC4R genes—key receptors that determine your metabolic response profile. If your genetic pattern shows strong GLP-1 pathway sensitivity, semaglutide alone may deliver excellent results. If your genetics suggest less robust GLP-1 response or stronger GIPR involvement, tirzepatide (which targets both GLP-1 and GIP receptors) might be more effective—insights available for $99 after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Mastering Your Ozempic Injection: Why You Can Take Ozempic In Your Thigh (And How)
Where Should I Inject Zepbound for Best Results?